 Matthew Galbraith
Concepts (264)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 13 | 2025 | 478 | 2.100 |
Why?
| | Cyclin-Dependent Kinase 8 | 8 | 2025 | 43 | 1.890 |
Why?
| | Cyclin-Dependent Kinases | 8 | 2025 | 126 | 1.550 |
Why?
| | Interferons | 6 | 2025 | 189 | 1.410 |
Why?
| | Transcriptome | 6 | 2024 | 875 | 1.240 |
Why?
| | Tumor Suppressor Protein p53 | 9 | 2023 | 503 | 1.230 |
Why?
| | Transcription, Genetic | 9 | 2021 | 1416 | 1.160 |
Why?
| | Transcriptional Activation | 9 | 2023 | 366 | 1.030 |
Why?
| | Mediator Complex | 3 | 2013 | 57 | 0.870 |
Why?
| | Blood | 1 | 2022 | 105 | 0.740 |
Why?
| | Neoplasms | 8 | 2023 | 2454 | 0.740 |
Why?
| | Proteome | 3 | 2024 | 440 | 0.730 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2024 | 274 | 0.710 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.700 |
Why?
| | Protein Kinase Inhibitors | 3 | 2025 | 886 | 0.640 |
Why?
| | Genomics | 2 | 2021 | 716 | 0.620 |
Why?
| | RNA Polymerase II | 7 | 2019 | 317 | 0.560 |
Why?
| | Signal Transduction | 10 | 2025 | 4935 | 0.560 |
Why?
| | Antineoplastic Agents | 4 | 2023 | 2044 | 0.550 |
Why?
| | Cell Hypoxia | 2 | 2017 | 234 | 0.520 |
Why?
| | ets-Domain Protein Elk-1 | 2 | 2013 | 13 | 0.500 |
Why?
| | Mitogens | 2 | 2013 | 61 | 0.500 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 170 | 0.470 |
Why?
| | Serum Response Element | 2 | 2011 | 5 | 0.440 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 22 | 0.410 |
Why?
| | Promoter Regions, Genetic | 3 | 2016 | 1213 | 0.340 |
Why?
| | Hypoxia | 4 | 2024 | 1085 | 0.340 |
Why?
| | Humans | 48 | 2025 | 129687 | 0.330 |
Why?
| | Anemia, Sickle Cell | 2 | 2023 | 253 | 0.320 |
Why?
| | Eosinophilic Esophagitis | 2 | 2024 | 318 | 0.310 |
Why?
| | Gene Expression Regulation, Neoplastic | 5 | 2021 | 1327 | 0.280 |
Why?
| | Cell Line, Tumor | 7 | 2023 | 3184 | 0.270 |
Why?
| | Nuclear Proteins | 4 | 2023 | 660 | 0.270 |
Why?
| | Glutamine | 2 | 2023 | 100 | 0.260 |
Why?
| | Cell Proliferation | 6 | 2023 | 2378 | 0.260 |
Why?
| | Tumor Suppressor Proteins | 2 | 2018 | 311 | 0.250 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 493 | 0.240 |
Why?
| | Animals | 17 | 2025 | 35404 | 0.240 |
Why?
| | Pantoea | 1 | 2004 | 2 | 0.230 |
Why?
| | Phenazines | 1 | 2004 | 9 | 0.230 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1441 | 0.230 |
Why?
| | Glutamate-Ammonia Ligase | 1 | 2004 | 7 | 0.230 |
Why?
| | Datasets as Topic | 2 | 2022 | 109 | 0.230 |
Why?
| | Apoptosis | 6 | 2023 | 2489 | 0.230 |
Why?
| | Janus Kinase Inhibitors | 1 | 2024 | 26 | 0.230 |
Why?
| | Immunoglobulins | 1 | 2025 | 162 | 0.220 |
Why?
| | Erythropoiesis | 1 | 2024 | 51 | 0.220 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2024 | 43 | 0.220 |
Why?
| | Heme | 1 | 2024 | 77 | 0.220 |
Why?
| | Hemoglobin SC Disease | 1 | 2023 | 13 | 0.220 |
Why?
| | Blood-Brain Barrier | 1 | 2025 | 132 | 0.220 |
Why?
| | HCT116 Cells | 3 | 2019 | 76 | 0.210 |
Why?
| | Oxidative Phosphorylation | 1 | 2024 | 188 | 0.210 |
Why?
| | Liposarcoma | 1 | 2023 | 26 | 0.210 |
Why?
| | Sickle Cell Trait | 1 | 2023 | 13 | 0.210 |
Why?
| | Hematopoiesis | 2 | 2021 | 184 | 0.210 |
Why?
| | Piperidines | 1 | 2024 | 200 | 0.200 |
Why?
| | Cell Line | 4 | 2025 | 2779 | 0.200 |
Why?
| | Protein Tyrosine Phosphatases | 2 | 2023 | 165 | 0.200 |
Why?
| | HeLa Cells | 3 | 2013 | 611 | 0.200 |
Why?
| | Fibroblasts | 2 | 2019 | 954 | 0.200 |
Why?
| | Proteomics | 3 | 2025 | 1058 | 0.200 |
Why?
| | Cerebellar Neoplasms | 1 | 2023 | 150 | 0.190 |
Why?
| | Transcription Factors | 3 | 2023 | 1645 | 0.190 |
Why?
| | Imidazoles | 2 | 2020 | 235 | 0.180 |
Why?
| | Medulloblastoma | 1 | 2023 | 191 | 0.180 |
Why?
| | Enteritis | 1 | 2022 | 93 | 0.180 |
Why?
| | Cell Differentiation | 3 | 2024 | 1900 | 0.180 |
Why?
| | Pyrimidines | 1 | 2024 | 458 | 0.180 |
Why?
| | Erythrocyte Transfusion | 1 | 2023 | 181 | 0.180 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 30 | 0.180 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2023 | 443 | 0.180 |
Why?
| | Autoimmunity | 2 | 2024 | 863 | 0.180 |
Why?
| | Erythrocytes | 2 | 2023 | 673 | 0.180 |
Why?
| | Genes, Tumor Suppressor | 1 | 2021 | 84 | 0.170 |
Why?
| | Case-Control Studies | 3 | 2025 | 3381 | 0.170 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 157 | 0.170 |
Why?
| | Glycolysis | 2 | 2024 | 314 | 0.170 |
Why?
| | Oncogenes | 1 | 2021 | 110 | 0.170 |
Why?
| | Piperazines | 2 | 2020 | 339 | 0.170 |
Why?
| | RNA Helicases | 1 | 2020 | 24 | 0.170 |
Why?
| | Databases, Genetic | 1 | 2021 | 228 | 0.170 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 4 | 2023 | 63 | 0.160 |
Why?
| | Gene Regulatory Networks | 1 | 2021 | 280 | 0.150 |
Why?
| | Mice | 10 | 2024 | 16982 | 0.150 |
Why?
| | Interferon-alpha | 1 | 2019 | 194 | 0.150 |
Why?
| | SOXB1 Transcription Factors | 1 | 2019 | 57 | 0.150 |
Why?
| | Epithelial Cells | 1 | 2024 | 1063 | 0.150 |
Why?
| | Metabolome | 1 | 2021 | 339 | 0.140 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 26 | 0.140 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 13 | 0.140 |
Why?
| | Hexokinase | 1 | 2017 | 18 | 0.140 |
Why?
| | Complement Activation | 1 | 2021 | 385 | 0.140 |
Why?
| | Complement System Proteins | 1 | 2021 | 319 | 0.140 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 406 | 0.140 |
Why?
| | Inpatients | 1 | 2022 | 477 | 0.140 |
Why?
| | Deoxyglucose | 1 | 2017 | 52 | 0.140 |
Why?
| | Homeostasis | 1 | 2021 | 605 | 0.140 |
Why?
| | Gene Editing | 1 | 2017 | 68 | 0.130 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 363 | 0.130 |
Why?
| | Lysine Acetyltransferase 5 | 1 | 2016 | 2 | 0.130 |
Why?
| | Osteosarcoma | 1 | 2017 | 70 | 0.130 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 388 | 0.130 |
Why?
| | Purines | 1 | 2017 | 172 | 0.130 |
Why?
| | Biomarkers | 3 | 2025 | 3969 | 0.130 |
Why?
| | Acetylation | 2 | 2016 | 244 | 0.130 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 177 | 0.130 |
Why?
| | Comorbidity | 1 | 2021 | 1551 | 0.130 |
Why?
| | Interferon-gamma | 1 | 2019 | 773 | 0.130 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2019 | 193 | 0.130 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 792 | 0.120 |
Why?
| | Conserved Sequence | 1 | 2016 | 227 | 0.120 |
Why?
| | NIH 3T3 Cells | 2 | 2013 | 140 | 0.120 |
Why?
| | Histone Acetyltransferases | 1 | 2016 | 61 | 0.120 |
Why?
| | Down-Regulation | 1 | 2017 | 631 | 0.120 |
Why?
| | Tretinoin | 1 | 2016 | 121 | 0.120 |
Why?
| | Nerve Tissue Proteins | 1 | 2019 | 569 | 0.120 |
Why?
| | Bone Neoplasms | 1 | 2017 | 229 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2019 | 378 | 0.110 |
Why?
| | HEK293 Cells | 2 | 2016 | 697 | 0.110 |
Why?
| | Drosophila Proteins | 1 | 2016 | 187 | 0.110 |
Why?
| | DNA Helicases | 1 | 2016 | 146 | 0.110 |
Why?
| | Drosophila melanogaster | 1 | 2016 | 211 | 0.110 |
Why?
| | Biomarkers, Tumor | 2 | 2019 | 1161 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2004 | 1708 | 0.110 |
Why?
| | Genes, Immediate-Early | 1 | 2013 | 19 | 0.110 |
Why?
| | Models, Biological | 1 | 2021 | 1724 | 0.110 |
Why?
| | Hemoglobin, Sickle | 2 | 2023 | 18 | 0.110 |
Why?
| | Phosphorylation | 2 | 2019 | 1716 | 0.110 |
Why?
| | Genes, ras | 1 | 2013 | 95 | 0.100 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 627 | 0.100 |
Why?
| | Protein Binding | 4 | 2021 | 2122 | 0.100 |
Why?
| | Hypoxia-Inducible Factor 1 | 1 | 2013 | 72 | 0.100 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2019 | 956 | 0.100 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2012 | 11 | 0.100 |
Why?
| | Gene Expression Regulation | 3 | 2025 | 2545 | 0.100 |
Why?
| | Receptors, TNF-Related Apoptosis-Inducing Ligand | 1 | 2012 | 29 | 0.090 |
Why?
| | bcl-2-Associated X Protein | 1 | 2012 | 55 | 0.090 |
Why?
| | Histones | 2 | 2016 | 588 | 0.090 |
Why?
| | Female | 12 | 2025 | 68751 | 0.090 |
Why?
| | Hospitalization | 1 | 2021 | 2075 | 0.090 |
Why?
| | Gene Silencing | 2 | 2023 | 190 | 0.090 |
Why?
| | Immunity, Innate | 1 | 2016 | 804 | 0.090 |
Why?
| | Proto-Oncogene Proteins | 3 | 2023 | 634 | 0.080 |
Why?
| | Yeasts | 1 | 2010 | 52 | 0.080 |
Why?
| | Gene Expression Profiling | 3 | 2024 | 1686 | 0.080 |
Why?
| | Phenotype | 3 | 2023 | 3062 | 0.080 |
Why?
| | Adult | 7 | 2025 | 35607 | 0.080 |
Why?
| | MCF-7 Cells | 2 | 2020 | 114 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2008 | 12 | 0.070 |
Why?
| | Breast Neoplasms | 1 | 2020 | 2104 | 0.070 |
Why?
| | Child | 5 | 2025 | 20882 | 0.070 |
Why?
| | Neoplasm Metastasis | 2 | 2020 | 610 | 0.070 |
Why?
| | Cell Cycle Proteins | 2 | 2023 | 583 | 0.070 |
Why?
| | Cytokines | 2 | 2024 | 2022 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 808 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2019 | 930 | 0.060 |
Why?
| | Child, Preschool | 3 | 2024 | 10487 | 0.060 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2343 | 0.060 |
Why?
| | Adolescent | 4 | 2025 | 20415 | 0.060 |
Why?
| | Male | 7 | 2025 | 63691 | 0.060 |
Why?
| | Genetic Complementation Test | 1 | 2004 | 64 | 0.060 |
Why?
| | Mutagenesis, Insertional | 1 | 2004 | 64 | 0.060 |
Why?
| | Mice, Knockout | 2 | 2023 | 2888 | 0.060 |
Why?
| | Genes, Bacterial | 1 | 2004 | 159 | 0.060 |
Why?
| | Hydroxyurea | 1 | 2023 | 34 | 0.050 |
Why?
| | Pyrroles | 1 | 2024 | 202 | 0.050 |
Why?
| | Glutamates | 1 | 2023 | 57 | 0.050 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 20 | 0.050 |
Why?
| | Erythropoietin | 1 | 2024 | 88 | 0.050 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 42 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Young Adult | 3 | 2025 | 12457 | 0.050 |
Why?
| | Proline | 1 | 2023 | 76 | 0.050 |
Why?
| | Receptors, Interferon | 1 | 2023 | 50 | 0.050 |
Why?
| | DNA, Bacterial | 1 | 2004 | 323 | 0.050 |
Why?
| | Sphingosine | 1 | 2023 | 40 | 0.050 |
Why?
| | RNA, Messenger | 2 | 2021 | 2702 | 0.050 |
Why?
| | Tyrosine | 1 | 2023 | 223 | 0.050 |
Why?
| | Kynurenine | 1 | 2023 | 113 | 0.050 |
Why?
| | Lysophospholipids | 1 | 2023 | 72 | 0.050 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 149 | 0.050 |
Why?
| | Cyclins | 1 | 2022 | 88 | 0.050 |
Why?
| | Mutation | 1 | 2013 | 3705 | 0.050 |
Why?
| | Growth Disorders | 1 | 2022 | 81 | 0.050 |
Why?
| | Esophagus | 1 | 2024 | 248 | 0.050 |
Why?
| | Bile Acids and Salts | 1 | 2023 | 195 | 0.050 |
Why?
| | Hemolysis | 1 | 2023 | 199 | 0.050 |
Why?
| | Middle Aged | 4 | 2025 | 31165 | 0.050 |
Why?
| | Sequence Analysis, DNA | 1 | 2004 | 778 | 0.050 |
Why?
| | Stress, Physiological | 1 | 2024 | 411 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.040 |
Why?
| | Clonal Evolution | 1 | 2021 | 39 | 0.040 |
Why?
| | Escherichia coli | 1 | 2004 | 766 | 0.040 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2022 | 310 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 110 | 0.040 |
Why?
| | Polyribosomes | 1 | 2020 | 22 | 0.040 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 33 | 0.040 |
Why?
| | BRCA1 Protein | 1 | 2020 | 65 | 0.040 |
Why?
| | Molecular Sequence Data | 1 | 2004 | 2833 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2020 | 95 | 0.040 |
Why?
| | Vesiculovirus | 1 | 2019 | 16 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 138 | 0.040 |
Why?
| | STAT1 Transcription Factor | 1 | 2019 | 70 | 0.040 |
Why?
| | Nanog Homeobox Protein | 1 | 2019 | 13 | 0.040 |
Why?
| | Biomedical Research | 1 | 2025 | 640 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 393 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 35 | 0.040 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2020 | 201 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 88 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2021 | 398 | 0.040 |
Why?
| | Mice, SCID | 1 | 2019 | 350 | 0.040 |
Why?
| | Up-Regulation | 1 | 2021 | 836 | 0.040 |
Why?
| | Kaplan-Meier Estimate | 1 | 2020 | 851 | 0.040 |
Why?
| | Cell Survival | 1 | 2021 | 1086 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2019 | 587 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 417 | 0.030 |
Why?
| | Autoantibodies | 1 | 2024 | 1468 | 0.030 |
Why?
| | Promyelocytic Leukemia Protein | 1 | 2016 | 4 | 0.030 |
Why?
| | Leukemia, Promyelocytic, Acute | 1 | 2016 | 12 | 0.030 |
Why?
| | Base Sequence | 1 | 2020 | 2142 | 0.030 |
Why?
| | Retinoic Acid Receptor alpha | 1 | 2016 | 15 | 0.030 |
Why?
| | Protein Domains | 1 | 2017 | 254 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2019 | 355 | 0.030 |
Why?
| | Mitosis | 1 | 2017 | 179 | 0.030 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2016 | 33 | 0.030 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2016 | 43 | 0.030 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2016 | 32 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 652 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2019 | 1248 | 0.030 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2016 | 132 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2019 | 1160 | 0.030 |
Why?
| | Cholesterol | 1 | 2017 | 412 | 0.030 |
Why?
| | Protein Subunits | 1 | 2016 | 233 | 0.030 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2016 | 99 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2016 | 329 | 0.030 |
Why?
| | Repressor Proteins | 1 | 2017 | 404 | 0.030 |
Why?
| | Survival Rate | 1 | 2019 | 1872 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 450 | 0.030 |
Why?
| | RNA, Small Interfering | 1 | 2016 | 590 | 0.030 |
Why?
| | Monocytes | 1 | 2016 | 553 | 0.030 |
Why?
| | Disease Progression | 1 | 2021 | 2628 | 0.030 |
Why?
| | Quality of Life | 1 | 2025 | 2694 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2023 | 4076 | 0.030 |
Why?
| | Prospective Studies | 1 | 2025 | 7145 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 478 | 0.020 |
Why?
| | Caspase 8 | 1 | 2012 | 48 | 0.020 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2016 | 752 | 0.020 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2012 | 182 | 0.020 |
Why?
| | Infant | 1 | 2024 | 8987 | 0.020 |
Why?
| | Binding Sites | 1 | 2014 | 1251 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2013 | 457 | 0.020 |
Why?
| | Prognosis | 1 | 2019 | 3772 | 0.020 |
Why?
| | Protein Transport | 1 | 2012 | 429 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 4892 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5468 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2016 | 4102 | 0.020 |
Why?
| | Early Growth Response Protein 1 | 1 | 2008 | 28 | 0.020 |
Why?
| | Genes, fos | 1 | 2008 | 33 | 0.020 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1937 | 0.020 |
Why?
| | RNA | 1 | 2014 | 876 | 0.020 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 215 | 0.020 |
Why?
| | Mitochondria | 1 | 2012 | 875 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2008 | 590 | 0.010 |
Why?
|
|
Galbraith's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|